BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 224 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2021. The put-call ratio across all filers is 1.19 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $729,000 | +4.9% | 5,000 | -14.7% | 0.25% | +30.3% |
Q1 2022 | $695,000 | -10.9% | 5,860 | +3.5% | 0.20% | -7.6% |
Q4 2021 | $780,000 | +24.8% | 5,660 | +25.8% | 0.21% | +17.2% |
Q3 2021 | $625,000 | +43.0% | 4,500 | 0.0% | 0.18% | +40.6% |
Q2 2021 | $437,000 | +41.9% | 4,500 | 0.0% | 0.13% | +30.6% |
Q1 2021 | $308,000 | -26.1% | 4,500 | -7.6% | 0.10% | -30.5% |
Q4 2020 | $417,000 | +42.3% | 4,870 | +8.2% | 0.14% | +17.5% |
Q3 2020 | $293,000 | +48.7% | 4,500 | +66.7% | 0.12% | -7.0% |
Q2 2020 | $197,000 | +20.9% | 2,700 | -10.0% | 0.13% | +53.6% |
Q4 2019 | $163,000 | +96.4% | 3,000 | +50.0% | 0.08% | +82.6% |
Q3 2019 | $83,000 | – | 2,000 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RP Management, LLC | 2,111,111 | $144,294,000 | 54.16% |
Knoll Capital Management, LLC | 856,844 | $58,565,000 | 38.16% |
ORACLE INVESTMENT MANAGEMENT INC | 2,123,271 | $145,126,000 | 21.73% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 860,261 | $58,799,000 | 6.01% |
ARS Investment Partners, LLC | 561,442 | $38,375,000 | 4.46% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $12,057,000 | 3.19% |
Eventide Asset Management | 2,015,000 | $137,725,000 | 2.04% |
Avidity Partners Management LP | 1,049,800 | $71,754,000 | 1.98% |
SILVERARC CAPITAL MANAGEMENT, LLC | 50,089 | $3,424,000 | 1.87% |
Nicholas Investment Partners, LP | 375,654 | $25,676,000 | 1.79% |